# Development of an influenza D virus with an eight- or nine-segment genome

**Authors:** Hiroho Ishida, Hironobu Murakami, Shuntaro Mizuno, Misa Katayama, Wataru Sekine, Kosuke Ohira, Akiko Takenaka-Uema, Shin Murakami, Makoto Nagai, Taisuke Horimoto

PMC · DOI: 10.1038/s41598-025-34838-y · 2026-01-08

## TL;DR

Researchers developed influenza D viruses with eight or nine genome segments to study protein functions and explore vaccine development.

## Contribution

They created IDVs with split M and NS segments for independent protein analysis and potential vaccine use.

## Key findings

- Eight- and nine-segment IDVs were successfully generated using reverse genetics.
- Split M and NS segments allowed independent expression of P42, M1, NS1, and NS2 proteins.
- The engineered viruses showed reduced replication in cell culture, suggesting potential for live attenuated vaccines.

## Abstract

Influenza D virus (IDV) contains seven genome segments. The M and NS segments are regulated via splicing to express two proteins each (P42 and M1 from the M segment and NS1 and NS2 from the NS segment). Previously, we created an eight-segment IDV by separating the NS1 and NS2 genes into independent monocistronic segments. In this study, we designed another eight-segment IDV with two divided M segments, transcribing either P42 or M1 mRNA independently. Specifically, we constructed two plasmids for reverse genetics: one for viral RNA (vRNA) synthesis of the P42 segment with silent mutations at the splicing donor site and one for vRNA synthesis of the M1 segment with deletion of the intron in the M segment. We successfully created the virus via reverse genetics using these two segments and six other vRNA synthesis plasmids (PB2, PB1, P3, HEF, NP, and NS). Furthermore, we generated a nine-segment IDV including the P42, M1, NS1, and NS2 segments. These systems enable independent functional and interactive analyses of M and NS segment-encoded proteins for viral infectivity. Additionally, the eight- and nine-segment IDVs exhibited significantly reduced replication in cell culture compared with wild-type IDV, suggesting a strategy for attenuated live vaccine development.

The online version contains supplementary material available at 10.1038/s41598-025-34838-y.

## Linked entities

- **Genes:** m (miniature) [NCBI Gene 44835], KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845], PB2 (polymerase PB2) [NCBI Gene 956536], SMR3A (submaxillary gland androgen regulated protein 3A) [NCBI Gene 26952], ATP5MC3 (ATP synthase membrane subunit c locus 3) [NCBI Gene 518], HEF (hemagglutinin-esterase-fusion) [NCBI Gene 3077359], PNP (purine nucleoside phosphorylase) [NCBI Gene 4860], PTPN11 (protein tyrosine phosphatase non-receptor type 11) [NCBI Gene 5781], LZTR1 (leucine zipper like post translational regulator 1) [NCBI Gene 8216], PSMC6 (proteasome 26S subunit, ATPase 6) [NCBI Gene 5706], CHRM1 (cholinergic receptor muscarinic 1) [NCBI Gene 1128]
- **Proteins:** PSMC6 (proteasome 26S subunit, ATPase 6), CHRM1 (cholinergic receptor muscarinic 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), LZTR1 (leucine zipper like post translational regulator 1)

## Full-text entities

- **Genes:** EPB42 (erythrocyte membrane protein band 4.2) [NCBI Gene 2038] {aka PA, SPH5}, IVNS1ABP (influenza virus NS1A binding protein) [NCBI Gene 10625] {aka ARA3, FLARA3, HSPC068, IMD70, KLHL39, ND1}, SPINK5 (serine peptidase inhibitor Kazal type 5) [NCBI Gene 11005] {aka LEKTI, LETKI, NETS, NS, VAKTI}, NS2 [NCBI Gene 57762]
- **Species:** Influenza D virus (no rank) [taxon 1511084]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12873286/full.md

---
Source: https://tomesphere.com/paper/PMC12873286